RADNOR, Pa.--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX, http://polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, announced that data will be presented on its heptagonist compounds at the annual meeting of the American Society of Hematology in Atlanta, Georgia.
